Filing Details
- Accession Number:
- 0001209191-10-054139
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-10 12:27:35
- Reporting Period:
- 2010-11-09
- Filing Date:
- 2010-11-10
- Accepted Time:
- 2010-11-10 12:27:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
949858 | Oncogenex Pharmaceuticals Inc. | OGXI | In Vitro & In Vivo Diagnostic Substances (2835) | 954343413 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1486333 | William Cameron Lawrence | 400 - 1001 West Broadway Vancouver A1 V6H 4B1 | Principal Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-11-09 | 650 | $15.73 | 3,050 | No | 4 | P | Indirect | RRSP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | RRSP |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 475 | Indirect | Spouse RRSP |